In summary, the background context has three components: (a) GLP-1 medications are clinically important but costly and administratively challenging
The American Diabetes Association (ADA) recommends insulin as the preferred agent for glycemic control during pregnancy due to its established safety profile and inability to cross the placental barrier in significant amounts
L-carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1-Parkin-dependent mitophagy through the CPT1a-PHB2-PARL pathways
Two therapies are showing promise in helping women take control of their health: Hormone Replacement Therapy (HRT) restores estrogen balance
It means morning and evening applications serve different purposes
Inoue A, Salimian Rizi B, Carugo A, Seth S, Bristow C, Genovese G, Viale A, Menter DG, Kopetz S , Draetta GF